Skip to main navigation
Home
  • Our Company
    • Biopharmaceutical Acceleration Model
    • Dynamic Assembly®
    • Kinetic
    • Syneos One®
    • The Trusted Process®
    • Our Leadership
    • Our Vision, Mission and Values
    • Resource Library
    • Events
    • Awards
    • Site Relationships
    • Our Office Locations
  • Solutions
    • Clinical Development
      • Full Service
        • Bioanalytical Solutions
        • Early Phase
        • Phase II - III
        • Phase IIIb - IV
        • Real World and Late Phase
        • Medical Device and Diagnostics
      • FSP 360
        • Biostatistics and Statistical Programming
        • Clinical Data Management
        • Clinical Development Services Project Management
        • Clinical Monitoring
        • Drug Safety and Pharmacovigilance
        • Investigator Management Solutions
        • Medical Writing and Communications
        • Rater Training
        • Site Start Up
        • Site and Patient Access
        • Trial Master File Operations
    • Commercialization
      • Advertising
      • Behavioral Insights
      • Brand Commercialization
      • Brand Naming and Development
      • Clinical Field Teams
      • Commercial Model of the Future
      • Commercial Recruiting Solutions
      • Communications
      • Deployment Solutions
      • Digital and Social Media
      • Health Economics and Outcomes Research
      • Integrated Commercial Solutions
      • Medical Affairs Transformation
      • Medical Communications
      • Medication Engagement
      • Policy and Advocacy
      • Portfolio Strategy
      • Public Relations
      • REMS and Risk Management (PMO)
      • Reputation and Risk Management
      • Selling Solutions
      • Syndicated Market Research and Insights
      • Training and Learning Solutions
      • Value and Access
    • Consulting
      • Commercial Advisory Group
        • Portfolio Strategy and Transactions
        • Health Economics and Outcomes Research
        • Product and Franchise Strategy
        • Value and Access
        • Customer and Digital Engagement
      • Scientific and Medical Affairs Advisory Group
        • Medical Affairs
        • Quality and Compliance
        • Regulatory
      • Risk and Program Management Advisory Group
        • REMS and Risk Management (PMO)
      • R&D Advisory Group
        • Research and Development
    • Syneos One®
  • Therapeutic Expertise
    • Therapeutic Areas
      • Cardiovascular
      • Central Nervous System
        • CNS Analgesia
        • CNS Clinical Surveillance Team
        • CNS Neurology
        • CNS Psychiatry
      • Endocrine and Metabolic
      • Gastroenterology
      • Immunology and Inflammation
      • Infectious Disease
      • Oncology and Hematology
        • Targeted Therapies
        • Novel and Emerging Therapies
        • Immuno-Oncology
      • Ophthalmology
      • Respiratory
      • Women's Health
    • Cross-Functional Solutions
      • Biosimilars
      • Cell and Gene Therapy
      • Pediatrics
      • Rare Diseases
    • Our Experience Hub
  • Insights Hub
  • Careers
  • News
    • In The News
    • Press Releases
    • Press Kit
  • Investors
  • Investigators
  • Transparency
  • Suppliers
  • Contact

Search form

Home Investors
Code of Business Conduct and Ethics

Code of Business Conduct and Ethics

Q3 2022 Syneos Health Inc. Earnings Conference Call

Scroll
  • Overview
  • News & Events
    • News
    • Events and Presentations
  • Stock Performance
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Management Team
    • Board of Directors
    • Committee Composition
    • Governance Documents
  • Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  • Investor Resources
    • Investor FAQs
    • Investor Contact
    • Forward-Looking Statement

Code of Business Conduct and Ethics

Code of Business Conduct and Ethics
English 4.4 MB
Chinese 2.9 MB
Dutch 35.5 MB
French 9.2 MB
German 4 MB
Italian 2.5 MB
Japanese 4.5 MB
Korean 31.9 MB
Polish 32 MB
Portuguese 18.9 MB
Russian 2.5 MB
Spanish 4 MB

Sign Up for Email Alerts

 
Subscribe Now
Interested in Syneos Health?
Get In Touch
Connect
  • LinkedInLinkedIn
  • TwitterTwitter
  • FacebookFacebook
  • InstagramInstagram

Syneos Health

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 28,000 clinical and commercial minds with the ability to support customers in more than 110 countries.

Contact Us
map HQ
Corporate Headquarters
  • 1030 Sync Street
  • Morrisville, NC 27560 

  • Phone:+1 919 876 9300
  • Fax:+1 919 876 9360
  • Toll-free:+1 866 462 7373
Menu
  • Solutions
  • Therapeutic Expertise
  • Brand Directory
  • Careers
  • Study Participants
  • Media
  • Business Ethics Helpline
  • Events
  • Transparency
© 2023 Syneos Health. All Rights Reserved.
  • Terms Of Use
  • Privacy Policy